Bionow’s 2025 Neuroscience conference tackles the challenge of combining expertise, funding and new technologies

-

Venue: Sheffield United Football Club

Following the success of its first year, the Bionow Neuroscience conference was back at Bramall Lane in Sheffield. More than 110 delegates came together to highlight the strengths in the discovery, development and commercialisation of neuroscience treatments and technologies across the north of England and beyond.

Read the full event summary here 
 

The 2025 Neuroscience conference was sponsored by ApconiX and the University of Sheffield.

 

Agenda highlights:

Keynote Speakers

  • Simon Stott, Director of Research, Cure Parkinsons
  • Fiona Ducotterd, CSO (Department of Neuromuscular Diseases), Alzheimer's Research UK

 

State of the Nation Panel

Chair: Heather Mortiboys, Head of Neuroscience, University of Sheffield

Speakers

  • Simon Stott, Director of Research, Cure Parkinsons
  • Anu Sethi, Director of Business Development, Sterling Pharma
  • Cassie Doherty, Investment Director, Northern Gritstone
  • Martin de Kort, Scientific Officer, REMDi4ALL
  • Sara Imariso, Strategy Leader - Neuroscience, Medicines Discovery Catapult

 

Translational Neuroscience and Commercialisation

Chair: Nicholas Coltman, Deputy Head of Safety Science, ApconiX

Speakers

  • Neil Miller, CEO, NRG Therapeutics
  • Simon Chandler, CEO, Rinri Therapeutics
  • Jennifer Fletcher, Research Associate, b-neuro

 

Psychiatric Disorders

Chair: Laura Ajram, Chief Executive, British Neuroscience Association

Speakers

  • Nick Sireau, CEO, Serenatis Bio
  • Kiri Granger, Co-Founder & CSO, Monument Therapeutics
  • Dimitri F. Dimitriou, Executive Chairman, Neurentis
  • Ekta Patel, Partnership Manager - Neuroscience, Medicines Discovery Catapult

 

Poster Spotlight

 

Poster Competition Announcement

 

Patient Perspective

Chair: Nick Sireau, Co-Founder & Chair, Orchard OCD

Patient: Shaun Flores, Mental Health, DEI, Neurodiversity & Masculinity Advocate, Orchard OCD

 

Drug Delivery to the Brain

Chair: Geoff Davison, CEO, Bionow

Speakers

  • Mike Morton, Co-Director, ApconiX
  • David Dickens, Principal Investigator – Pharmacology and Therapeutics, University of Liverpool
  • Alan Whone, Professor of Movement Disorders Neurology, University of Bristol
  • Claire Thompson, Formulation Advisor, Celestial Health

 

Sensory and Rare Conditions

Chair: David Holmes, Membership Manager, Bionow

Speakers

  • Walter Marcotti, Professor of Sensory Neuroscience, University of Sheffield
  • Benedict Michael, Professor of Neuroscience, MRC Clinician Scientist and Honorary Consultant Neurologist, University of Liverpool
  • Mimoun Azzouz, Chair of Translational Neuroscience, University of Sheffield
  • Farid Khan, CSO, Chief AI

 

"Sip and Cerebration" drinks and canapés - hosted by ApconiX